🇺🇸 FDA
Pipeline program

S-Amlodipine TAB (VAM) 1.25 mg, Amlodipine 2.5 mg

PERLA

Phase 2 small_molecule active

Quick answer

S-Amlodipine TAB (VAM) 1.25 mg, Amlodipine 2.5 mg for Patients with moderate or severe oedema on a long-term treatment with amlodipine is a Phase 2 program (small_molecule) at Zentiva k.s. with 1 ClinicalTrials.gov record(s).

Program details

Company
Zentiva k.s.
Indication
Patients with moderate or severe oedema on a long-term treatment with amlodipine
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials